Blair Leavitt

Huntington drug successfully lowers levels of disease-causing protein

An international clinical trial has found that a new drug for Huntington disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating disease in patients.

May 6, 2019

CBD may help Huntington’s

Castanet reported that Blair Leavitt, a UBC professor in the department of medical genetics and department of medicine, spoke at a national Huntington disease conference.

Nov 5, 2018